Payment overview · 2025
General Payments
$36.15
2 reported records · 2 companies
Healthcare provider profile · identity verified
Robert H Hunter, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · HAMPTON, VA · NPI 1427023340
Verified facts
What the public records show
CMS Open Payments records show Robert H Hunter, M.D. received $36.15 in general payments during 2025 across 2 reported records.
Corcept Therapeutics accounted for 50.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
PBG PUERTO RICO LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 738 records involving 435 distinct recipient NPIs. Public Medicare Part D data also shows 126 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Corcept Therapeutics | Unresolved — no canonical attribution shown | $18.32 | 50.7% | 1 | 2025 |
| PBG PUERTO RICO LLC | Unresolved — no canonical attribution shown | $17.83 | 49.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $36.15 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Korlym Normalized: korlym |
Drug | Corcept Therapeutics | $18.32 | 1 | 2025 |
Source payment records
|
|||||
| XYNTHA Normalized: xyntha |
Biological | PBG PUERTO RICO LLC | $17.83 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PBG PUERTO RICO LLC Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 738 supporting records · 435 recipient NPIs · example record 1228798592 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
126 | 28 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 852 | 219 |
| Atorvastatin Calcium | Atorvastatin Calcium | 713 | 209 |
| Omeprazole | Omeprazole | 436 | 118 |
| Losartan Potassium | Losartan Potassium | 380 | 101 |
| Levothyroxine Sodium | Levothyroxine Sodium | 370 | 94 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 338 | 96 |
| Simvastatin | Simvastatin | 331 | 91 |
| Metformin Hcl | Metformin Hcl | 328 | 91 |
| Lisinopril | Lisinopril | 324 | 86 |
| Hydrochlorothiazide | Hydrochlorothiazide | 323 | 97 |
| Duloxetine Hcl | Duloxetine Hcl | 305 | 91 |
| Tamsulosin Hcl | Tamsulosin Hcl | 271 | 82 |
| Hydralazine Hcl | Hydralazine Hcl | 249 | 66 |
| Potassium Chloride | Potassium Chloride | 249 | 74 |
| Metoprolol Succinate | Metoprolol Succinate | 242 | 72 |
| Furosemide | Furosemide | 223 | 73 |
| Gabapentin | Gabapentin | 207 | 55 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 181 | 59 |
| Pantoprazole Sodium | Pantoprazole Sodium | 179 | 50 |
| Fluticasone Propionate | Fluticasone Propionate | 156 | 55 |
| Glipizide Er | Glipizide | 154 | 45 |
| Montelukast Sodium | Montelukast Sodium | 149 | 45 |
| Pravastatin Sodium | Pravastatin Sodium | 138 | 34 |
| Eliquis | Apixaban | 126 | 28 |
| Prednisone | Prednisone | 124 | 45 |
| Sertraline Hcl | Sertraline Hcl | 120 | 35 |
| Trazodone Hcl | Trazodone Hcl | 115 | 41 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 112 | 35 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 111 | 28 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 105 | 28 |
| Tramadol Hcl | Tramadol Hcl | 103 | 18 |
| Clopidogrel | Clopidogrel Bisulfate | 101 | 28 |
| Allopurinol | Allopurinol | 100 | 28 |
| Metformin Hcl Er | Metformin Hcl | 100 | 33 |
| Jardiance | Empagliflozin | 99 | 29 |
| Buspirone Hcl | Buspirone Hcl | 96 | 27 |
| Carvedilol | Carvedilol | 93 | 29 |
| Ezetimibe | Ezetimibe | 93 | 31 |
| Metoprolol Tartrate | Metoprolol Tartrate | 91 | 30 |
| Pioglitazone Hcl | Pioglitazone Hcl | 85 | 23 |
| Ibuprofen | Ibuprofen | 83 | 25 |
| Meloxicam | Meloxicam | 82 | 22 |
| Clonidine Hcl | Clonidine Hcl | 80 | 20 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 78 | 24 |
| Linzess | Linaclotide | 77 | 22 |
| Memantine Hcl | Memantine Hcl | 75 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 75 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 74 | 21 |
| Ozempic | Semaglutide | 70 | suppressed |
| Atenolol | Atenolol | 69 | 17 |
| Alendronate Sodium | Alendronate Sodium | 67 | 18 |
| Rybelsus | Semaglutide | 66 | 19 |
| Diclofenac Sodium | Diclofenac Sodium | 65 | 26 |
| Spironolactone | Spironolactone | 65 | 17 |
| Cephalexin | Cephalexin | 63 | 38 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 63 | 19 |
| Colchicine | Colchicine | 58 | 16 |
| Fenofibrate | Fenofibrate Nanocrystallized | 58 | 14 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 57 | 13 |
| Glipizide | Glipizide | 54 | 17 |
| Dicyclomine Hcl | Dicyclomine Hcl | 53 | 11 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 52 | suppressed |
| Finasteride | Finasteride | 50 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 50 | 15 |
| Meclizine Hcl | Meclizine Hcl | 47 | 14 |
| Warfarin Sodium | Warfarin Sodium | 47 | 16 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 46 | 13 |
| Synthroid | Levothyroxine Sodium | 46 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 46 | 15 |
| Azelastine Hcl | Azelastine Hcl | 45 | 21 |
| Ketoconazole | Ketoconazole | 44 | 26 |
| Lovastatin | Lovastatin | 44 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 42 | suppressed |
| Baclofen | Baclofen | 39 | 11 |
| Mupirocin | Mupirocin | 39 | 18 |
| Donepezil Hcl | Donepezil Hcl | 38 | 15 |
| Benazepril Hcl | Benazepril Hcl | 37 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 36 | 11 |
| Glimepiride | Glimepiride | 36 | 11 |
| Indapamide | Indapamide | 34 | suppressed |
| Nifedipine Er | Nifedipine | 34 | suppressed |
| Azithromycin | Azithromycin | 32 | 26 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 32 | suppressed |
| Famotidine | Famotidine | 32 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 32 | 12 |
| Januvia | Sitagliptin Phosphate | 32 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 32 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 32 | 18 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 31 | 12 |
| Nortriptyline Hcl | Nortriptyline Hcl | 31 | suppressed |
| Nitroglycerin | Nitroglycerin | 30 | 17 |
| Fenofibrate | Fenofibrate | 28 | suppressed |
| Levetiracetam | Levetiracetam | 28 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 27 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 26 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 26 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 20 |
| Xarelto | Rivaroxaban | 25 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 24 | 12 |
| Repaglinide | Repaglinide | 24 | suppressed |
| Lorazepam | Lorazepam | 23 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 23 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 23 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 23 | suppressed |
| Verapamil Er | Verapamil Hcl | 23 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 22 | suppressed |
| Felodipine Er | Felodipine | 22 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 21 | suppressed |
| Estradiol | Estradiol | 21 | suppressed |
| Metolazone | Metolazone | 21 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 21 | suppressed |
| Ondansetron Odt | Ondansetron | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Fluconazole | Fluconazole | 20 | suppressed |
| Fluocinonide | Fluocinonide | 20 | suppressed |
| Klor-Con M10 | Potassium Chloride | 20 | suppressed |
| Pregabalin | Pregabalin | 20 | suppressed |
| Telmisartan | Telmisartan | 20 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 19 | suppressed |
| Lidocaine | Lidocaine | 19 | suppressed |
| Methocarbamol | Methocarbamol | 19 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 19 | suppressed |
| Celecoxib | Celecoxib | 18 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | suppressed |
| Methylprednisolone | Methylprednisolone | 18 | 17 |
| Solifenacin Succinate | Solifenacin Succinate | 18 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 18 | 14 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 17 | 14 |
| Labetalol Hcl | Labetalol Hcl | 17 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Nystatin | Nystatin | 17 | 11 |
| Trulicity | Dulaglutide | 17 | suppressed |
| Acyclovir | Acyclovir | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | 14 |
| Clobetasol Propionate | Clobetasol Propionate | 16 | suppressed |
| Methimazole | Methimazole | 16 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 16 | suppressed |
| Testosterone | Testosterone | 16 | suppressed |
| Topiramate | Topiramate | 16 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 15 | suppressed |
| Dutasteride | Dutasteride | 14 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 14 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 14 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 14 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 13 | suppressed |
| Amoxicillin | Amoxicillin | 13 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 13 | suppressed |
| Butalb-Acetaminoph-Caff-Codein | Butalbit/Acetamin/Caff/Codeine | 13 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Clonazepam | Clonazepam | 13 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 13 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 13 | suppressed |
| Klor-Con M20 | Potassium Chloride | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 13 | suppressed |
| Naproxen | Naproxen | 13 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 13 | suppressed |
| Ramipril | Ramipril | 13 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 12 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 12 | suppressed |
| Dutasteride-Tamsulosin | Dutasteride/Tamsulosin Hcl | 12 | suppressed |
| Etodolac | Etodolac | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Estradiol (Twice Weekly) | Estradiol | 11 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Invokana | Canagliflozin | 11 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 11 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $36.15 · 2 records | Corcept Therapeutics | Korlym, XYNTHA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with PBG PUERTO RICO LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error